Guatam Sethi

Sethi Guatam

Appointment(s)
  • Associate Professor, Department of Pharmacology
Administrative Appointment(s)
  • Safety Lead, Safety and Health Committee, Department of Pharmacology
Academic Qualifications
  • PhD, Banaras Hindu University, India
  • MSc, Banaras Hindu University, India
  • BSc (Honours), Banaras Hindu University, India
Research Interest(s)
  • Transcription Factors
  • Cell Signaling
  • Chemoprevention
  • Pharmaceuticals
Recent Publications
  • 1. Selvi RB, Swaminathan A, Chatterjee S, Shanmugam MK, Li F, Ramakrishnan GB, Siveen KS, Chinnathambi A, Zayed ME, Alharbi SA, Basha J, Bhat A, Vasudevan M, Dharmarajan A, Sethi G, Kundu TK. 2015 Dec. Inhibition of p300 lysine acetyltransferase activity by luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model. Oncotarget. 6(41):43806-18. doi: 10.18632/oncotarget.6245. 26517526.
  • 2. Perumal Samy R, Manikandan J, Pachiappan A, Ooi EE, Aw LT, Stiles BG, Franco OL, Kandasamy M, Mathi KM, Rane G, Siveen KS, Arunachalam C, Zayed ME, Alharbi SA, Kumar AP, Sethi G, Lim LH, Chow VT. 2015. Gene Microarray Analyses of Daboia russelli russelli Daboiatoxin Treatment of THP-1 Human Macrophages Infected with Burkholderia pseudomallei. Curr Mol Med. 15(10):961-74. doi: 10.2174/1566524016666151123114123. 26592245.
  • 3. Singh SS, Yap WN, Arfuso F, Kar S, Wang C, Cai W, Dharmarajan AM, Sethi G, Kumar AP. 2015 Nov. Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?. World J Gastroenterol. 21(43):12261-73. doi: 10.3748/wjg.v21.i43.12261. 26604635.
  • 4. Samy RP, Stiles BG, Chinnathambi A, Zayed ME, Alharbi SA, Franco OL, Rowan EG, Kumar AP, Lim LH, Sethi G. 2015 Oct. Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent. FEBS Open Bio. 5:928-41. doi: 10.1016/j.fob.2015.10.004. 26793432.
  • 5. Kim SM, Kim C, Bae H, Lee JH, Baek SH, Nam D, Chung WS, Shim BS, Lee SG, Kim SH, Sethi G, Ahn KS. 2015 Oct. 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways. Mol Carcinog. 54(10):1132-46. doi: 10.1002/mc.22184. 24962868.